12:29 EST Solventum (SOLV) jumps 2% to $70.74 after CNBC report of Trian letter
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SOLV:
- GE Vernova initiated, Merck upgraded: Wall Street’s top analyst calls
- Solventum initiated with a Neutral at Mizuho
- Trian exits Disney stake, takes new position in Ferguson
- Solventum price target raised to $73 from $60 at Morgan Stanley
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
